semaglutide fat vs muscle loss Weight with GLP-1 medicines does not result in a disproportionate loss of mass or function in obese mice and humans: Cell Reports Medicine Semaglutide 2.4 mg and lean

Methodology and Sources This analysis is based on publicly available sources as of December 26, 2025: FDA communications: Compounding safety alerts, prescribing information, and regulatory guidance Novo Nordisk announcements: Wegovy pill approval, OASIS 4 trial results, pricing disclosures Independent reporting and primary sources: ABC News coverage and Novo Nordisks announcement on December 22, 2025 FDA oral Wegovy approval MEDVi terms and disclosures: Platform structure, pricing, and regulatory disclaimers Key Sources Cited: ABC News: "FDA approves Wegovy pill for weight loss" (December 22, 2025) Novo Nordisk: Official press release on FDA approval and OASIS 4 trial data (December 22, 2025) FDA Safety Communications: 20242025 alerts on compounded semaglutide dosing errors All regulatory references are based on FDA publications and third-party reporting available at the time of publication

The symptoms would likely just be GI related as opposed to anything more serious

Gentle activity like walking often helps improve energy levels rather than worsening them

D., Blher, M., Tschp, M